Trademark Overview
On Tuesday, January 13, 2026, a trademark application was filed for THERAPEUTIC TARGETING (THETA) with the United States Patent and Trademark Office. The USPTO has given the THERAPEUTIC TARGETING (THETA) trademark a serial number of 99591522. The federal status of this trademark filing is NEW APPLICATION - RECORD INITIALIZED NOT ASSIGNED TO EXAMINER as of Tuesday, January 13, 2026. This trademark is owned by Korsana Biosciences, Inc.. The THERAPEUTIC TARGETING (THETA) trademark is filed in the Pharmaceutical Products and Computer & Software Services & Scientific Services categories with the following description:
Pharmaceutical preparations for the treatment of neurological conditions, neurodegenerative conditions, central nervous system (CNS) conditions, cardiac conditions, muscle conditions, bone marrow conditions, and tumors; Drug delivery agents consisting of antibodies or antibody fragments, sold as an integral component of pharmaceuticals; Antibodies or antibody fragments for medical purposes; Antibody or antibody fragment-containing compounds for medical purposes
Pharmaceutical research and development